Cargando…

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer

Detalles Bibliográficos
Autores principales:	Dalla, Emiliano, Picco, Raffaella, Novara, Giacomo, Moro, Fabrizio Dal, Brancolini, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921352/ https://www.ncbi.nlm.nih.gov/pubmed/35288800 http://dx.doi.org/10.1186/s43556-022-00069-0

Ejemplares similares

HDAC7‐mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
por: Cutano, Valentina, et al.
Publicado: (2019)

Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency
por: Iuliano, Luca, et al.
Publicado: (2022)

Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
por: Di Giorgio, Eros, et al.
Publicado: (2020)

HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
por: Di Giorgio, Eros, et al.
Publicado: (2021)

Transcriptomic Analysis Unveils Correlations between Regulative Apoptotic Caspases and Genes of Cholesterol Homeostasis in Human Brain
por: Picco, Raffaella, et al.
Publicado: (2014)

Genetic Programs Driving Oncogenic Transformation: Lessons from In Vitro Models
por: Di Giorgio, Eros, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy
por: Zattoni, Fabio, et al.
Publicado: (2023)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

Nomograms in Urologic Oncology: Lights and Shadows
por: Morlacco, Alessandro, et al.
Publicado: (2021)

Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report
por: Dal Moro, Fabrizio, et al.
Publicado: (2023)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients
por: Carando, Roberto, et al.
Publicado: (2020)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
por: Carta, Angela, et al.
Publicado: (2018)

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
por: Jin, Subin, et al.
Publicado: (2017)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions
por: Zuniga, Kyle B., et al.
Publicado: (2020)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Does obesity impact bladder cancer prognosis?—a long-lasting debate
por: Dal Moro, Fabrizio, et al.
Publicado: (2018)

Urology: a trip into metaverse
por: Randazzo, Gianmarco, et al.
Publicado: (2023)

Novel protein signatures suggest progression to muscular invasiveness in bladder cancer
por: Berle, Magnus, et al.
Publicado: (2018)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
por: Mitrakas, Lampros P., et al.
Publicado: (2015)

Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
por: Song, Yuxuan, et al.
Publicado: (2020)

Are we following the guidelines on non-muscle invasive bladder cancer?
por: Reis, Leonardo Oliveira, et al.
Publicado: (2016)

Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction
por: Casarin, Martina, et al.
Publicado: (2022)

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
por: Lin, Ying-Li, et al.
Publicado: (2014)

Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models
por: Choi, Se Young, et al.
Publicado: (2014)

EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients
por: Borkowska, Edyta M., et al.
Publicado: (2013)

Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus
por: Ahn, Ji Hoon, et al.
Publicado: (2016)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
por: Bryan, Richard T., et al.
Publicado: (2023)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pt5kvkrr7a7bh10hjbk01et00o